Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|June 29, 2024
IMHB-Mediated Chameleonicity in Drug Design: A Focus on Structurally Related PROTACsDiego Garcia Jimenez, Matteo Rossi Sebastiano, Maura Vallaro, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Bellerophon: An Automated Tool for PROTAC DecompositionGiulia Apprato, Matteo Bertola, Amelia Locatelli, et al.
Molecules (Basel, Switzerland)|October 27, 2022
Personalized Treatment for Infantile Ascending Hereditary Spastic Paralysis Based on In Silico StrategiesMatteo Rossi Sebastiano, Giuseppe Ermondi, Kai Sato, et al.
Protein Science : a Publication of the Protein Society|December 26, 2024
Restoring adapter protein complex 4 function with small molecules: an in silico approach to spastic paraplegia 50Serena Francisco, Lorenzo Lamacchia, Attilio Turco, et al.
Journal of Medicinal Chemistry|August 1, 2025
Linker Methylation as a Strategy to Enhance PROTAC Oral Bioavailability: Insights from Molecular Properties and Conformational AnalysisDiego Garcia Jimenez, Giuseppe Ermondi, Zuzana Jandova, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 26, 2021
Permeability prediction in the beyond-Rule-of 5 chemical space: Focus on cyclic hexapeptidesVito Digiesi, Víctor de la Oliva Roque, Maura Vallaro, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 15, 2021
Rifampicin as an example of beyond-rule-of-5 compound: Ionization beyond water and lipophilicity beyond octanol/waterGiuseppe Ermondi, Maura Vallaro, Jaan Saame, et al.
Dalton Transactions (Cambridge, England : 2003)|December 25, 2012
Molecular interaction fields vs. quantum-mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexesGiuseppe Ermondi, Giulia Caron, Mauro Ravera, et al.
Dalton Transactions (Cambridge, England : 2003)|March 30, 2022
Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(IV) complexes to obtain antiproliferative agents against human glioblastoma cellsElisabetta Gabano, Marzia Bruna Gariboldi, Giulia Caron, et al.
Pageof 10